Back by popular demand! NutraIngredients to host Immunity Webinar on 28 June
With immunity continuing to play on the minds of consumers and industry players, NutraIngredients' global team presents the latest in science, innovation and regulation in a webinar scheduled for 28 June at 11:00 CET.
NutraIngredients’ Science and Technology Editor Will Chu says with the success of previous years' broadcasts, the appetite is still there to learn about how best to optimise immune health.
"As well as bringing our audience up to speed on the latest and greatest in scientific research, these sessions will reveal some of the key challenges and opportunities in developing and marketing products with immune health benefits.
“I look forward to getting stuck into this topic and looking at if the past couple of years have had an influence on the commercialisation of ingredients known for their immune health benefits.
"With expert speakers ranging from scientists to manufacturers, market analysts to start-up founders, I hope to cover the breadth of questions on the lips of our readers right now.”
Building on the success of our inaugural series in May 2020 and the Immunity Broadcast Series of 2021, this webinar, hosted by the EMEA team, will include live and interactive presentations and panel discussions with top industry experts.
A few of the industry experts expected to join the webinar include Ruud Albers, founder and CSO of NutriLeads and Mark Miller, President of Kaiviti Consulting.
Also joining the line-up is Dr Karsten Krüger, Professor of Exercise Physiology and Sports Therapy at the Justus-Liebig-University Gießen, Germany.
The broadcast also welcomes Kappa Bioscience as this year’s Diamond sponsor and Atlantia Clinical Trials as a webinar Supporter.
The 2022 Immunity Interactive Broadcast Series for the EMEA swiftly follows the APAC region’s broadcast on 26 April, where the team discussed consumer demand for immunity-boosting products post-pandemic.
The APAC broadcast, which is now available on-demand, bought together experts to assess the existing scientific evidence, the scope for new product development, the opportunity for gold-standard clinical research and the marketing and regulatory challenges across the region.
As always, the Immunity Interactive Broadcast Series is FREE and pre-registration is required. Please note you need to register for each broadcast that you wish to attend.